Table 3. Treatment efficacy of the infantile hemangioma in 12 children who received oral propranolol.
Patient No. | Tx. Duration (mo) | Age at end of Tx. (mo) | Total treatment response score | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 Mo | 3 Mo | 6 Mo | 12 Mo | |||||||||||||||
Color | LD | Th | Sum | Color | LD | Th | Sum | Color | LD | Th | Sum | Color | LD | Th | Sum | |||
1 | 12 | 12.0 | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 5 | 2 | 1 | 3 | 6 | 3 | 2 | 3 | 8 |
2 | 12 | 21.0 | 1 | 0 | 1 | 2 | 2 | 1 | 2 | 5 | 2 | 1 | 2 | 5 | 3 | 1 | 2 | 6 |
3 | 12 | 16.1 | 1 | 1 | 2 | 4 | 1 | 1 | 3 | 5 | 2 | 2 | 3 | 7 | 3 | 3 | 3 | 9 |
4 | 12 | 13.8 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 4 | 1 | 2 | 3 | 6 | 2 | 2 | 3 | 7 |
5 | 4 | 9.5 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | - | - | - | - | - | - | - | - |
6 | 12 | 13.0 | 1 | 1 | 3 | 5 | 2 | 1 | 3 | 6 | 2 | 2 | 3 | 7 | 3 | 3 | 3 | 9 |
7 | 12 | 15.8 | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 5 | 2 | 2 | 2 | 6 | 3 | 2 | 3 | 8 |
8 | 12 | 15.9 | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 6 | 2 | 2 | 3 | 7 | 3 | 2 | 3 | 8 |
9 | 12 | 16.3 | 2 | 1 | 1 | 4 | 2 | 1 | 2 | 5 | 2 | 2 | 3 | 7 | 3 | 2 | 3 | 8 |
10 | 12 | 16.2 | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 5 | 2 | 2 | 3 | 7 | 3 | 2 | 3 | 8 |
11 | 12 | 16.0 | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 5 | 2 | 2 | 2 | 6 | 3 | 2 | 3 | 8 |
12 | 12 | 15.0 | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 5 | 2 | 1 | 3 | 6 | 2 | 2 | 3 | 7 |
Tx., treatment; LD, longest diameter; Th, thickness.